Abstract
The efficacy of a bronchodilator combination therapy (a slow-release xanthine derivative plus an oralβ 2-mimetic—tulobuterol) in the treatment of nocturnal asthma attacks was compared to the efficacy of a monotherapy using a xanthine derivative alone.
Similar content being viewed by others
References
Barnes P, Neville L, Greening AP, Timmers J (1982) Single-dose slow release aminophylline at night prevents nocturnal asthma. Lancet 1:299
Bellia V, Cuttitta G, Insalaco G, Visconti A, Bonsignore G (1989) Relationship of nocturnal bronchoconstriction to sleep stages. Amer Rev Resp Dis 129:27–32
Fairfax AJ, NcNabb WR, Davies JH, Spiro SG (1980) Slow-release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels. Thorax 35:526
Milledge JS, Morris J (1979) A comparison of slow release salbutamol with slow-release aminophylline in nocturnal asthma. J Int Med Res 7:106
Rhind GB, Connaughton JJ, McFie J, Doublas NJ, Flenley DC (1985) Sustained release choline theophyllinate in nocturnal asthma. Brit Med J 291:1605
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rühle, K.H., Dorow, P. & Schmitz-Schumann, H. Effects of a combined treatment theophylline and tulobuterol on nocturnal chronic asthma. Lung 168 (Suppl 1), 192–193 (1990). https://doi.org/10.1007/BF02718132
Issue Date:
DOI: https://doi.org/10.1007/BF02718132